The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependencyMathew Sheridan, Georges Lacaud|Journal of Hematology & Oncology|2024Cited by 9